This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales).

Monitoring Fabry disease nephropathy

Speaker

Professor Camila Tøndel
University of Bergen and Haukeland University Hospital

Discussion Points

Renal damage caused by Fabry disease begins early and progresses silently
The clinical relevance of globotriaosylceramide (GL-3) accumulation

Monitoring Fabry disease nephropathy

Download a short presentation on monitoring Fabry disease nephropathy.

DOWNLOAD

MAT-XU-2300202 (v1.0)
Date of preparation: March 2023

YOU ARE NOW LEAVING THE SANOFI CAMPUS UK WEBSITE

You are going to a website that is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

Continue

Welcome to Sanofi Campus UK

This site is intended for UK healthcare professionals only and contains information on Sanofi UK’s medicines, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a UK healthcare professional. This site contains promotional information. Please note that some of the content on the website is only relevant for HCPs practising in Great Britain (England, Scotland, Wales).

MAT-XU-2300297 (v1.0)
Date of Preparation: February 2023